Capital Fund Management (CFM)
ABBV icon

Capital Fund Management (CFM)’s AbbVie ABBV Stock Holding History

Capital Fund Management (CFM)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.63M Sell
39,700
-148,700
-79% -$33M 0.04% 613
2025
Q4 		$43M Sell
188,400
-4,400
-2% -$1M 0.12% 216
2025
Q3 		$44.6M Sell
192,800
-46,600
-19% -$9.49M 0.12% 222
2025
Q2 		$44.4M Buy
239,400
+25,800
+12% +$4.79M 0.12% 232
2025
Q1 		$44.8M Buy
213,600
+38,800
+22% +$7.54M 0.13% 226
2024
Q4 		$31.1M Sell
174,800
-100,800
-37% -$18.5M 0.08% 337
2024
Q3 		$54.4M Sell
275,600
-48,600
-15% -$9.07M 0.15% 181
2024
Q2 		$55.6M Sell
324,200
-22,100
-6% -$3.66M 0.16% 177
2024
Q1 		$63.1M Buy
346,300
+292,400
+542% +$50.4M 0.18% 147
2023
Q4 		$8.35M Sell
53,900
-164,100
-75% -$23.9M 0.02% 869
2023
Q3 		$32.5M Buy
218,000
+78,200
+56% +$11.5M 0.11% 235
2023
Q2 		$18.8M Buy
139,800
+20,500
+17% +$3.01M 0.08% 350
2023
Q1 		$19M Sell
119,300
-183,000
-61% -$28M 0.09% 295
2022
Q4 		$48.9M Sell
302,300
-247,600
-45% -$38M 0.33% 59
2022
Q3 		$73.8M Buy
549,900
+74,200
+16% +$10.6M 0.58% 20
2022
Q2 		$72.9M Buy
475,700
+143,400
+43% +$21.9M 0.66% 11
2022
Q1 		$53.9M Buy
332,300
+294,700
+784% +$42.8M 0.44% 25
2021
Q4 		$5.09M Buy
37,600
+14,200
+61% +$1.68M 0.04% 634
2021
Q3 		$2.52M Sell
23,400
-26,200
-53% -$2.99M 0.02% 831
2021
Q2 		$5.59M Sell
49,600
-172,500
-78% -$19.4M 0.04% 519
2021
Q1 		$24M Buy
222,100
+35,962
+19% +$3.85M 0.27% 99
2020
Q4 		$19.9M Sell
186,138
-96,100
-34% -$9.23M 0.19% 136
2020
Q3 		$24.7M Buy
282,238
+1,200
+0.4% +$113K 0.31% 92
2020
Q2 		$27.6M Buy
281,038
+172,738
+159% +$15.2M 0.44% 49
2020
Q1 		$8.25M Sell
108,300
-2,100
-2% -$179K 0.13% 214
2019
Q4 		$9.78M Buy
110,400
+82,300
+293% +$6.83M 0.08% 343
2019
Q3 		$2.13M Sell
28,100
-47,400
-63% -$3.25M 0.02% 765
2019
Q2 		$5.49M Sell
75,500
-31,200
-29% -$2.45M 0.05% 473
2019
Q1 		$8.6M Sell
106,700
-217,000
-67% -$17.8M 0.08% 336
2018
Q4 		$29.8M Sell
323,700
-349,200
-52% -$30.7M 0.26% 81
2018
Q3 		$63.6M Sell
672,900
-7,700
-1% -$730K 0.35% 41
2018
Q2 		$63.1M Sell
680,600
-144,600
-18% -$14.1M 0.33% 64
2018
Q1 		$78.1M Sell
825,200
-134,300
-14% -$14.8M 0.47% 20
2017
Q4 		$92.8M Buy
959,500
+644,300
+204% +$60.7M 0.51% 30
2017
Q3 		$28M Buy
315,200
+122,000
+63% +$9.29M 0.2% 146
2017
Q2 		$14M Buy
+193,200
New +$13M 0.11% 240
2017
Q1 		– Sell
-429,900
Closed -$26.9M – 1419
2016
Q4 		$26.9M Buy
429,900
+400,800
+1,377% +$24.5M 0.23% 115
2016
Q3 		$1.83M Sell
29,100
-89,100
-75% -$5.77M 0.02% 788
2016
Q2 		$7.32M Sell
118,200
-53,300
-31% -$3.25M 0.07% 328
2016
Q1 		$9.8M Sell
171,500
-344,100
-67% -$19.2M 0.1% 252
2015
Q4 		$30.5M Buy
515,600
+427,600
+486% +$24.6M 0.31% 70
2015
Q3 		$4.79M Sell
88,000
-28,400
-24% -$1.85M 0.05% 408
2015
Q2 		$7.82M Buy
116,400
+13,600
+13% +$888K 0.1% 274
2015
Q1 		$6.02M Buy
102,800
+71,600
+229% +$4.33M 0.08% 297
2014
Q4 		$2.04M Buy
31,200
+5,200
+20% +$328K 0.02% 678
2014
Q3 		$1.5M Buy
+26,000
New +$1.44M 0.02% 780
2014
Q1 		– Sell
-14,000
Closed -$739K – 1655
2013
Q4 		$739K Hold
14,000
– – 0.01% 1100
2013
Q3 		$626K Hold
14,000
– – 0.01% 1067
2013
Q2 		$579K Buy
+14,000
New +$612K 0.01% 960

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Fund Management (CFM)'s ABBV Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 22,088 shares — an estimated $4.9M sold.

Capital Fund Management (CFM) first reported a position in ABBV in Q2 2014 and held it in 28 quarters. The position peaked at $139M in Q3 2018. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 22,088 AbbVie shares in Q1 2026, an estimated $4.9M.
  • Capital Fund Management (CFM) first reported a position in AbbVie in Q2 2014 and held it in 28 quarters.
  • Capital Fund Management (CFM)'s AbbVie position peaked at $139M in Q3 2018.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.